1214899-99-6

Basic information

• Product Name: tert-butyl(dimethyl)[(4-methylenecyclohexyl)oxy]silane
• Synonyms: tert-butyl(dimethyl)[(4-methylenecyclohexyl)oxy]silane
• CAS NO: 1214899-99-6
• Molecular Weight: 226.434
• Mol File: 1214899-99-6.mol

Chemical Properties

• CAS DataBase Reference: tert-butyl(dimethyl)[(4-methylenecyclohexyl)oxy]silane(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl(dimethyl)[(4-methylenecyclohexyl)oxy]silane(1214899-99-6)
• EPA Substance Registry System: tert-butyl(dimethyl)[(4-methylenecyclohexyl)oxy]silane(1214899-99-6)

Safety Data

• Hazardous Substances Data: 1214899-99-6(Hazardous Substances Data)

Upstream product

• 13482-22-9 4-hydroxycyclohexanone 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 55145-45-4 4-(tert-butyldimethylsilyloxy)cyclohexanone 
• 1779-49-3 Methyltriphenylphosphonium bromide 

Downstream Products

• 1402011-64-6 9-(tert-butyldimethylsilyloxy)-2-(chloromethyl)-4-nosyl-1-oxa-4-azaspiro[5.5]undecane 
• 1402011-44-2 N-(2-(1-(bromomethyl)-4-(tert-butyldimethylsilyloxy)cyclohexyloxy)-3-chloropropyl)-4-nitrobenzenesulfonamide 
• 1402011-54-4 C₂₂H₃₆BrClN₂O₆SSi 

Relevant articles and documents

Construction of Distant Stereocenters by Enantioselective Desymmetrizing Carbonyl-Ene Reaction

An efficient desymmetrizing carbonyl-ene reaction of 1-substituted 4-methylenecyclohexanes with glyoxal derivatives was thus executed by a chiral N,N′-dioxide/NiII catalyst, providing facile access to cyclohexene derivatives bearing two remote 1,6-related stereocenters. This distal stereocontrol methodology originates from the efficient interaction between the catalyst with enophiles, discrimination of the two chair conformations of olefinic components, and the intrinsic six-membered transition-state structure of ene process.

NEW BICYCLIC DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES

The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.